Willkie advised Genstar Capital, while Davis Polk advised Numerix in the transaction. Genstar Capital executed the acquisition of Numerix, the leader in capital markets risk management...
You must be a Standard 1 Year member to access this content.
Davis Polk advised SVB Securities LLC, the sole initial purchaser, in the offering. Assertio Holdings, Inc. executed the offering of $70 million aggregate principal amount of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Oak Street Health, Inc. announced the $180.3 million secondary offering of 7,000,000 million shares of common stock...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Barclays Capital, the manager, in the offering. Arrival executed a SEC-registered at-the-market offering of its ordinary shares for up to an aggregate offering price of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent Jefferies in the offering. Vaccitech plc executed an at-the-marketing offering program of its American depositary shares representing its ordinary shares under...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised TransMedics, while Davis Polk advised representatives of the underwriters in the offering. TransMedics Group, Inc. executed its $150 million SEC-registered follow-on offering of...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Intel, while Davis Polk & Wardwell advised the underwriters on the offering. Intel Corporation executed the offering consisting of $1.25 billion aggregate principal...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Allakos, while Davis Polk advised the underwriter, Cowen, in the offering. Allakos Inc. announced it may issue and sell shares of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering. Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriter, SVB Securities, in the offering. Applied Therapeutics, Inc. announced its offering of 20,000,000 shares of common stock, pre-funded warrants to purchase up...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers, J.P. Morgan Securities LLC and Jefferie, in the offering. Deciphera Pharmaceuticals, Inc. executed a $172.5 million SEC-registered common stock and...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Excelerate Energy, while Davis Polk advised the representatives of the several underwriters in the IPO. Excelerate Energy, Inc. announced the $384 million...
You must be a Standard 1 Year member to access this content.
